Circulogene Theranostics Names James A. Posey III, M.D., As Chief Medical Advisor

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Circulogene Theranostics, the only biotechnology company able to enrich circulating cell-free DNA (cfDNA) from a single blood drop for patient-specific monitoring of cancer, has named medical oncologist James A. Posey III, M.D., as Chief Medical Advisor.

In his new role, Dr. Posey will help educate other oncologists about the efficacy and availability of Circulogene's cfDNA liquid biopsy products and will be responsible for further validation of the company's proprietary technology.

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

While the biotech IPO market booms, it can look like going public is easy. But the right strategy, syndicate and aftermarket are still important.

Gene therapy pioneer Jim Wilson and the University of Pennsylvania are teaming up with Regeneron to help deliver its COVID antibody intransally.

Forty percent of PK deficiency patients on mitapivat had hemoglobalin responses, compared to 0% in the placebo group.